SCHEMBL18152544

SCHEMBL18152544

COC(=O)c1cc(-c2ccc(COc3cccc4ccccc34)cc2)ccc1NS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 4/20 0.51
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
GAA P10253 2/20 0.46
KDM4E B2RXH2 1/20 0.46
AGTR1 P30556 1/20 0.46
POLB P06746 2/20 0.45
ALDH1A1 P00352 4/20 0.43
MAPT P10636 4/20 0.43
PLAT P00750 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
CNR1 P21554 1/20 0.43
HTT P42858 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
MCL1 Q07820 3/20 0.43
BCL2A1 Q16548 2/20 0.43
KAT6A Q92794 1/20 0.43
BCL2 P10415 1/20 0.42
BCL2L1 Q07817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18151709 0.91 MCL1 (0.52) GAAPOLBALDH1A1MAPTMCL1
SCHEMBL18151778 0.88 MCL1 (0.54) PLAUMEN1KMT2AGAAKDM4E
SCHEMBL18151728 0.83 BCL2L1 (0.49) PLAUMEN1KMT2AGAAKDM4E
SCHEMBL18151774 0.82 PLAU (0.55) PLAUMEN1KMT2AGAAKDM4E
SCHEMBL22762345 0.80 MCL1 (0.53) PLAUMEN1KMT2AGAAPOLB
SCHEMBL22213636 0.80 POLB (0.52) PLAUMEN1KMT2AGAAAGTR1
SCHEMBL18151745 0.79 MCL1 (0.63) MEN1KMT2APOLBLMNAMCL1
SCHEMBL18151749 0.78 MAPT (0.55) MEN1KMT2AGAAKDM4EPOLB
SCHEMBL18164555 0.75 MCL1 (0.53) MEN1KMT2AMCL1BCL2A1BCL2
SCHEMBL18152267 0.74 ACLY (0.55) PLAUMEN1KMT2AGAAPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3285583-B1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF UNIV MICHIGAN REGENTS (US) 2021-03-17 EP disclosed
EP-3285583-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF The Regents of The University of Michigan (US) 2018-02-28 EP disclosed
US-9884841-B2 Small molecule inhibitors of Mcl-1 and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-02-06 US disclosed
WO-2016172218-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-10-27 WO disclosed
US-20160304485-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304485-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF MCL1, BCL2L1, BCL2L11 PLAU 4571/4885MEN1 494/4885KMT2A 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.